Entering text into the input field will update the search result below

Hologic receives FDA clearance for Panther Fusion to test COVID-19

May 19, 2023 9:05 AM ETHologic, Inc. (HOLX)By: SA News Team
  • Hologic (NASDAQ:HOLX) said it had received U.S. FDA clearance for Panther Fusion SARS-CoV-2/Flu A/B/RSV assay
  • The assay detects and differentiates major respiratory viruses including SARS-CoV-2, flu A, flu B, and RSV.
  • The panther fusion system delivers initial results in approximately three hours, processing over 1,000 tests in 24 hours
  • New RespDirect collection kit simplifies sample loading, saving time and reducing errors
  • Project funded by U.S. Department of Health and Human Services
  • Hologic shipped over 200M SARS-CoV-2 tests worldwide, strengthens position as a leading molecular diagnostic company

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About HOLX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Hologic, Inc.
Sonova Holding AG
Olympus Corporation
Baxter International Inc.
Koninklijke Philips N.V.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.